Discovery of a Fluorinated Enigmol Analog with Enhanced in Vivo Pharmacokinetic and Anti-Tumor Properties

[Image: see text] The orally bioavailable 1-deoxy-sphingosine analog, Enigmol, has demonstrated anticancer activity in numerous in vivo settings. However, as no Enigmol analog with enhanced potency in vitro has been identified, a new strategy to improve efficacy in vivo by increasing tumor uptake wa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ACS Med Chem Lett
Main Authors: Miller, Eric J., Mays, Suzanne G., Baillie, Mark T., Howard, Randy B., Culver, Deborah G., Saindane, Manohar, Pruett, Sarah T., Holt, Jason J., Menaldino, David S., Evers, Taylor J., Reddy, G. Prabhakar, Arrendale, Richard F., Natchus, Michael G., Petros, John A., Liotta, Dennis C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Chemical Society 2016
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4867483/
https://ncbi.nlm.nih.gov/pubmed/27190606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.6b00113
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados